Equidacent: “The Committee adopted a positive opinion recommending the granting of a marketing authorization by consensus together with the CHMP assessment report and translation timetable [Solid tumors]”

Equidacent (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca, Centus Biotherap

Oct 29, 2020